Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering
CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue
Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems
Abstract 2037: Targeting chromosome rearrangements in cancer with CRISPR
168 STING-IFN-κ-APOBEC3G pathway mediates resistance to CRISPR transfection in keratinocytes
276 Autocrine IFN-κ restricts CRISPR-Cas9 Keratinocyte transfection through STING-APOBEC3G activation
Biochemical characterization of RNA-guided ribonuclease activities for CRISPR-Cas9 systems
Inserting DNA with CRISPR
CRISPR knockout screen implicates three genes in lysosome function
Abstract 4503: Functional CRISPR screen towards identifying novel conserved long noncoding RNAs with oncogenic activity
Abstract 4503: Functional CRISPR screen towards identifying novel conserved long noncoding RNAs with oncogenic activity
386 Autocrine IFN-k restricts CRISPR-Cas9 keratinocyte transfection
A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus
Insights into a Mysterious CRISPR Adaptation Factor, Cas4
Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis
Abstract 54: Genome-wide CRISPR screen identifies potential therapeutic combination of EGFR and FGFR inhibitors in oral cancer
A lentivirus-free inducible CRISPR-Cas9 system for efficient targeting of human genes
Abstract 3198: Using a genome-wide CRISPR-Cas9 knockout library to identify therapeutic combinations in oral cancer
Identification of ACE2 modifiers by CRISPR screening
Ann Arbor, MI
Footer
